1Mercadante S,Gebbia V,Marrazzo A,et al.Anaemia in cancer: pathophysiology and treatment[].Cancer Treatment Reviews.2000
2Koury MJ,Bondurant MC.Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells[].Science.1990
同被引文献30
1Dicato M, Plawny L, Diederich M. Anemia in cancer[J]. Ann Oncol, 2010, 21 Suppl 7 :vii167-172.
2Barni S, Cahiddu M, Guarneri P, et al. The risk for anemia with targeted therapies for solid tumors[J]. Oncologist, 2012,17(5) :715- 724.
3SzenajchJ, W cislo G,JeongJY , et al. The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells from clinic to bench-a critical review[J]. Biochim Biophys Acta, 2010, l806( 1) :82-95.
4Cao Y. Erythropoietin in cancer: a dilemma in risk therapy[J] . Trends Endocrinol Metab, 2013, 24(4) :190-199.
5Kawada N, Moriyama T, Ichimaru N, et al. Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patientsJ J }. Clin Exp Nephrol , 2009,13(4) :355-360.
6GroopmanJE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment[J]. Natl Cancer Inst , 1999, 91 ( 19) : 1616- 1634.
7Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS) : a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients[J]. EurJ Cancer, 2004, 40(15) :2293-2306.
8Seshadri T, Prince HM, Bell DR, et al. The Australian Cancer Anemia Survey: a snapshot of anemia in adult patients with cancer[J] . MedJ Aust, 2005,182(9) :453457.
9Qiu MZ, Xu RH, Ruan DY, et al. Incidence of anemia, leukocytosis and thrombocytosis in patients with solid tumors in China[J] . Tumour Biol , 2010, 31 (6) :633-641.
10Abdel-Razeq H, Abbasi S, Saadi I, et al. Intravenous iron monotherapy for tbe treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study[J]. Drug Des Devel Ther, 2013, 7 :939-944.
